Evidence map›Paper›PMID 28699691›Full record

ArticleAngewandte Chemie (International ed. in English)2017

Gold-Triggered Uncaging Chemistry in Living Systems.

Ana M Pérez-López, Belén Rubio-Ruiz, Víctor Sebastián, Lloyd Hamilton, Catherine Adam, Thomas L Bray, Silvia Irusta, Paul M Brennan, Guy C Lloyd-Jones, Dirk Sieger and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 184 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Selective Iridium-Catalyzed Reductive Amination Inside Living Cells.Journal of the American Chemical Society · 2025
    Article
  11. Exploring New Bioorthogonal Catalysts: Scaffold Diversity in Catalysis for Chemical Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  12. Article
  13. Review
  14. Repurposing Copper(II)/THPTA as A Bioorthogonal Catalyst for Thiazolidine Bond Cleavage.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Ana M Pérez-LópezCancer Research (UK) Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, UK.
Belén Rubio-RuizCancer Research (UK) Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, UK.ORCID 0000-0003-4720-6578
Víctor SebastiánDepartment of Chemical Engineering and Environmental Technology and Institute of Nanosciences of Aragon (INA), University of Zaragoza, Spain.ORCID 0000-0002-6873-5244
Lloyd HamiltonCentre for Neurogeneration, The Chancellor's Building, University of Edinburgh, UK.
Catherine AdamCancer Research (UK) Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, UK.
Thomas L BrayCancer Research (UK) Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, UK.
Silvia IrustaDepartment of Chemical Engineering and Environmental Technology and Institute of Nanosciences of Aragon (INA), University of Zaragoza, Spain.
Paul M BrennanCancer Research (UK) Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, UK.ORCID 0000-0002-7347-830X
Guy C Lloyd-JonesSchool of Chemistry, King's Buildings, West Mains Road, University of Edinburgh, UK.ORCID 0000-0003-2128-6864
Dirk SiegerCentre for Neurogeneration, The Chancellor's Building, University of Edinburgh, UK.
Jesús SantamaríaDepartment of Chemical Engineering and Environmental Technology and Institute of Nanosciences of Aragon (INA), University of Zaragoza, Spain.
Asier Unciti-BrocetaCancer Research (UK) Edinburgh Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, UK.ORCID 0000-0003-1029-2855
Edinburgh Cancer Research · GBUniversidad de Zaragoza · ESUniversity of Edinburgh · GB

Funding

Cancer Research UK 17494
6 · The paper itself

Abstract

Recent advances in bioorthogonal catalysis are increasing the capacity of researchers to manipulate the fate of molecules in complex biological systems. A bioorthogonal uncaging strategy is presented, which is triggered by heterogeneous gold catalysis and facilitates the activation of a structurally diverse range of therapeutics in cancer cell culture. Furthermore, this solid-supported catalytic system enabled locally controlled release of a fluorescent dye into the brain of a zebrafish for the first time, offering a novel way to modulate the activity of bioorthogonal reagents in the most fragile and complex organs.

Indexed as

A549 CellsAnimalsAntineoplastic AgentsBrainCatalysisDelayed-Action PreparationsFluorescent DyesGoldHumansZebrafishAntineoplastic AgentsDelayed-Action PreparationsFluorescent DyesGoldbioorthogonalfluorescent probesgoldheterogeneous catalysisprodrugs

Identifiers

PMID28699691
PMCPMC5655737
OpenAlexW2735509752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.